PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of RNA therapeutics in Australia. The company's preclinical development programs include VP-001, a drug program for retinitis pigmentosa type 11; PYC-001, a drug program for the treatment of autosomal dominant optic atrophy; and PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder. It also focuses on the development of programs for kidney, neurodevelopmental, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
| Market Capitalization | $223.972 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | 0 |
| Book Value | 0.008 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.01 |
| EBITDA | -22,801.012 |
| Profit Margin | -1.4418 |
| Operating Margin TTM | -1.4824 |
| Return on Assets TTM | -0.3549 |
| Return on Equity TTM | -0.6805 |
| Revenue TTM | 15,806.256 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2004-06-30 | 188 | |||
| 2005-06-30 | 52.556 | 43 | 52.556 | 1,793.475 |
| 2006-06-30 | 489 | 137.232 | -137.232 | 3,939.568 |
| 2007-06-30 | 275.385 | 272.496 | 2.889 | 4,698.662 |
| 2008-06-30 | 90.752 | 572 | 90.752 | 5,664.567 |
| 2009-06-30 | 1,274.942 | 1,144 | 1,274.942 | 4,977.516 |
| 2010-06-30 | 596.256 | 1,119 | 596.256 | 5,260.739 |
| 2011-06-30 | 2,358.532 | 3,039 | 2,358.532 | 6,076.221 |
| 2012-06-30 | 1,918.368 | 3,042 | 1,918.368 | 5,984.438 |
| 2013-06-30 | 712 | 3,267 | -3,000 | 6,104.53 |
| 2014-06-30 | 692.15 | 3,619 | 692.15 | 5,875.529 |
| 2015-06-30 | 763.393 | 581.26 | 763.393 | 5,862.412 |
| 2016-06-30 | 1.076 | 658.18 | -658.18 | 6,225.674 |
| 2017-06-30 | 2,760.258 | 993.17 | 2,760.258 | 7,014.339 |
| 2018-06-30 | 48.46 | 1,324.79 | -1,276.33 | 9,768.147 |
| 2019-06-30 | 0.25 | 1,837.42 | -1,837.17 | 7,102.101 |
| 2020-06-30 | 62.5 | 1,966.86 | -1,904.36 | 9,744.775 |
| 2021-06-30 | 3,078.17 | 21,832.848 | ||
| 2022-06-30 | 16,067.25 | 30,207.766 | ||
| 2023-06-30 | 15,888.11 | 39,163.123 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2004-06-30 | 791 | 1,174 | 628 | 899 | ||
| 2005-06-30 | 5,505.128 | 6,084.495 | 303.613 | 7,720.889 | ||
| 2006-06-30 | 2,638.872 | 2,832.213 | 717.909 | 12.703 | 7,820.452 | |
| 2007-06-30 | 3,369.322 | 3,533.984 | 1,337.322 | 9.679 | 11,709.889 | |
| 2008-06-30 | 3,232.073 | 3,519.002 | 824.364 | 7.087 | 16,675.573 | |
| 2009-06-30 | 3,072.905 | 3,487.221 | 1,575.977 | 1,028 | 20,093.323 | |
| 2010-06-30 | 1,281.044 | 1,570.04 | 2,007.12 | 1,237.691 | 21,973.323 | |
| 2011-06-30 | 5,199.473 | 5,661.077 | 1,308.354 | 30,367.388 | ||
| 2012-06-30 | 2,779.09 | 3,495.024 | 801.166 | 32,455.506 | ||
| 2013-06-30 | 1,806.905 | 2,262.461 | 1,067.588 | 34,055.506 | ||
| 2014-06-30 | 4,021.588 | 4,524.135 | 805.476 | 39,666.296 | ||
| 2015-06-30 | 1,475.869 | 1,785.839 | 823.805 | 39,666.296 | ||
| 2016-06-30 | 7,073.541 | 7,265.766 | 1,435.523 | 48,456.076 | ||
| 2017-06-30 | 9,939.943 | 10,348.258 | 1,489.208 | 0 | 53,209.076 | |
| 2018-06-30 | 3,147.306 | 3,419.054 | 1,771.777 | 0 | 53,334.289 | |
| 2019-06-30 | 6,181.403 | 6,701.242 | 401.874 | 0 | 61,951.088 | |
| 2020-06-30 | 6,942.343 | 31,546.314 | 1,350.783 | 152.967 | 87,206.823 | |
| 2021-06-30 | 18,435.199 | 57,940.854 | 4,016.593 | 187.53 | 125,991.333 | |
| 2022-06-30 | 29,110.023 | 45,351.748 | 5,149.451 | 259.8 | 125,991.333 | |
| 2023-06-30 | 15,571.534 | 37,165.898 | 8,723.299 | 177.816 | 140,087.345 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2004-06-30 | 28 | 791.227 | ||||
| 2005-06-30 | -1,587.323 | 4,713.901 | 791.227 | 5,505.128 | ||
| 2006-06-30 | -3,991.475 | -2,866.256 | 5,505.128 | 2,638.872 | ||
| 2007-06-30 | -3,888.673 | 730.45 | 2,638.872 | 3,369.322 | ||
| 2008-06-30 | -4,483.938 | -137.249 | 3,369.322 | 3,232.073 | ||
| 2009-06-30 | -4,490.92 | -159.168 | 3,232.073 | 3,072.905 | ||
| 2010-06-30 | -4,572.825 | -1,791.861 | 3,072.905 | 1,281.044 | ||
| 2011-06-30 | -3,605.169 | 3,918.429 | 1,281.044 | 5,199.473 | ||
| 2012-06-30 | -3,904.524 | -2,420.383 | 5,199.473 | 2,779.09 | ||
| 2013-06-30 | -3,439.624 | -2,000 | -972.185 | 2,779.09 | 1,806.905 | |
| 2014-06-30 | -3,257.695 | -3,200.291 | 2,214.683 | 1,806.905 | 4,021.588 | |
| 2015-06-30 | -2,991.479 | -2,481.25 | -2,545.719 | 4,021.588 | 1,475.869 | |
| 2016-06-30 | -3,978.672 | -3,166.73 | 5,597.672 | 1,475.869 | 7,073.541 | |
| 2017-06-30 | -1,950.837 | -1,883.136 | 2,866.402 | 7,073.541 | 9,939.943 | |
| 2018-06-30 | -7,433.997 | -6,707.273 | -6,792.637 | 9,939.943 | 3,147.306 | |
| 2019-06-30 | -4,079.768 | -5,125.413 | 3,034.097 | 3,147.306 | 6,181.403 | |
| 2020-06-30 | -6,822.215 | -5,748.405 | 5,280.493 | 1,661.85 | 6,942.343 | |
| 2021-06-30 | -17,767.586 | -11,791.314 | 11,192.856 | 7,242.343 | 18,435.199 | |
| 2022-06-30 | -14,326.563 | -13,487.058 | 10,674.824 | 18,435.199 | 29,110.023 | |
| 2023-06-30 | -22,788.985 | -24,421.686 | -13,538.489 | 29,110.023 | 15,571.534 |